Liquid Biopsy for Advanced NSCLC: IASLC Consensus Statement
Expert consensus on the clinical use of liquid biopsy in advanced NSCLC, including plasma circulating tumor DNA testing and its relationship to tissue-based testing.
Key Activities
Review evidence, benefits and limitations of plasma-based testing and next-generation sequencing. Support clinical implementation through a consensus publication and related educational webinar. Last updated in 2021 with 2027 update forthcoming.